Live tape
Top 8, mentions 7d2,137GOOGL453 mentions▲ +0.06NVDA345 mentions▲ +0.07META271 mentions▲ +0.05QQQ266 mentions▲ +0.09SPY256 mentions▲ +0.04AAPL193 mentions▲ +0.04MSFT178 mentions▲ +0.06TSLA175 mentions▲ +0.06

Equity · Financial Services

HLI

Houlihan Lokey, Inc. · NYSE

$130 −1.99% 1D Finazon · prior-day close · Sep 18, 2026
Price · Chart
Our own end-of-day closes 63 sessions
$150 $120 22 Jun 18 Sep

The line runs $140.99 on 22 June through $130 on 18 September, on a scale from $120 to $150. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of HLI over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 63 sessions over that window: $140.99 on 22 June 2026 through $130 on 18 September 2026.

Market cap $8.8B
P/E (TTM) 22.0
52-week range $123 – $209.17
Avg volume 59.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 20, 2026

HLI insider trades

SEC Form 4 · last 90 days · newest reported trade 10 Sep 2026
Open-market buys 1
Open-market sells 1
Net bought $360K
Non-trade filings 1
Date Insider Type Shares Value
10 Sep 2026 CRAIN CHRISTOPHER M GENERAL COUNSEL Sell 1,000 $140K
03 Aug 2026 ALLEY J LINDSEY Chief Financial Officer Buy 4,020 $501K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
10 Sep 2026 CRAIN CHRISTOPHER M GENERAL COUNSEL Other 1,000

HLI reported financials

SEC EDGAR XBRL

HLI reported revenue of $2.6B for the fiscal year ended 31 Mar 2026. Net income over the same period was $425.7M.

Figure Reported Period
Revenue $2.6B 31 Mar 2026 fiscal year
Net income $425.7M 31 Mar 2026 fiscal year
Diluted EPS $6.22 31 Mar 2026 fiscal year
Total assets $3.7B 30 Jun 2026 at period end
Total equity $2.3B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

HLI earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q1 2027 $1.15 $511M
31 Mar 2026 FY 2026 $6.22 $2.62B
31 Dec 2025 Q3 2026 $1.70 $717M
30 Sep 2025 Q2 2026 $1.63 $659M
30 Jun 2025 Q1 2026 $1.42 $605M
31 Mar 2025 FY 2025 $5.82 $2.39B
31 Dec 2024 Q3 2025 $1.39 $634M
30 Sep 2024 Q2 2025 $1.37 $575M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

HLI institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a HLI position for the quarter ended 30 Jun 2026 — a combined $382.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Added +151.5% shares 1,227,541 $164.7M
AQR Capital Management Held (±25%) +21.8% shares 486,239 $65.2M
Millennium Management Added +147.4% shares 375,874 $50.4M
D. E. Shaw & Co. Added +109.9% shares 290,765 $39.0M
Tudor Investment Corp Held (±25%) +13.4% shares 263,803 $35.4M
Two Sigma Investments Held (±25%) −19.7% shares 85,383 $11.5M
Renaissance Technologies New position 76,000 $10.2M
Man Group Added +26.5% shares 23,907 $3.2M
Bridgewater Associates Held (±25%) −22.1% shares 16,007 $2.1M
Fisher Asset Management Held (±25%) −4.7% shares 7,344 $985K

Source: SEC EDGAR 13F filings

HLI fails-to-deliver

SEC CNS data

On 31 Aug 2026, 896 shares of HLI failed to deliver (about $119K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 896 $119K 0.001%
27 Aug 2026 2 $260 <0.001%
14 Aug 2026 50 $7K <0.001%
11 Aug 2026 10 $1K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in HLI

STOCK Act disclosures

The most recent congressional trade disclosed in HLI is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 07 Aug 2026.

Date Member Type Amount
07 Aug 2026 filed 10 Sep 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
03 Mar 2026 filed 07 Apr 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures